Myocardial Ischemia and Cardioprotection: From Pathophysiology to Novel Therapeutic Targets

Ischemic heart disease remains the leading cause of death worldwide and is frequently complicated by myocardial ischemia–reperfusion (I/R) injury, which contributes substantially to infarct expansion, adverse ventricular remodeling, and heart failure. The pathophysiology of myocardial ischemia involves a complex interplay among energy depletion, intracellular acidosis, calcium overload, oxidative stress, mitochondrial dysfunction, and the activation of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death pathways. Endogenous cardioprotective mechanisms, including ischemic preconditioning, postconditioning, remote ischemic conditioning, heat shock proteins, bilirubin signaling, and mitochondrial quality-control pathways, have demonstrated potent infarct-limiting effects in experimental models. These protective responses are mediated through interconnected signaling networks which converge to preserve mitochondrial integrity, maintain calcium homeostasis, reduce oxidative stress, and enhance cell survival. In addition, innate and adaptive immune responses play critical roles in post-infarction repair and remodeling, although excessive and/or prolonged inflammation can exacerbate injury. Despite strong mechanistic evidence, the translation of cardioprotective therapies into clinical practice has been challenging due to comorbidities, patient heterogeneity, and the complexity of human disease. Emerging approaches, including mitochondrial-targeted antioxidants, cell-based therapies, anti-inflammatory interventions, ferroptosis inhibitors, and SGLT2 inhibitors, offer promising opportunities for developing effective, multifaceted cardioprotective strategies.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210395
Primary Topic
Cardiac Ischemia and Reperfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Myocardial Ischemia and Cardioprotection: From Pathophysiology to Novel Therapeutic Targets

Martin Elliot Young, David E. Stec, Alan J. Mouton, Michael I. Adenawoola et al.
International Journal of Molecular Sciences
Cardiac Ischemia and Reperfusion
article

Myocardial Ischemia and Cardioprotection: From Pathophysiology to Novel Therapeutic Targets

Martin Elliot Young, David E. Stec, Alan J. Mouton, Michael I. Adenawoola, Huaxiu Zeng, Mursalin Khan
article en

Abstract

Ischemic heart disease remains the leading cause of death worldwide and is frequently complicated by myocardial ischemia–reperfusion (I/R) injury, which contributes substantially to infarct expansion, adverse ventricular remodeling, and heart failure. The pathophysiology of myocardial ischemia involves a complex interplay among energy depletion, intracellular acidosis, calcium overload, oxidative stress, mitochondrial dysfunction, and the activation of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death pathways. Endogenous cardioprotective mechanisms, including ischemic preconditioning, postconditioning, remote ischemic conditioning, heat shock proteins, bilirubin signaling, and mitochondrial quality-control pathways, have demonstrated potent infarct-limiting effects in experimental models. These protective responses are mediated through interconnected signaling networks which converge to preserve mitochondrial integrity, maintain calcium homeostasis, reduce oxidative stress, and enhance cell survival. In addition, innate and adaptive immune responses play critical roles in post-infarction repair and remodeling, although excessive and/or prolonged inflammation can exacerbate injury. Despite strong mechanistic evidence, the translation of cardioprotective therapies into clinical practice has been challenging due to comorbidities, patient heterogeneity, and the complexity of human disease. Emerging approaches, including mitochondrial-targeted antioxidants, cell-based therapies, anti-inflammatory interventions, ferroptosis inhibitors, and SGLT2 inhibitors, offer promising opportunities for developing effective, multifaceted cardioprotective strategies.

International Journal of Molecular SciencesVol. 27(22)
University of Mississippi Medical Center (US), University of Alabama at Birmingham (US), UAB Medicine (US)
Cardiac Ischemia and Reperfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon